Singapore markets open in 6 hours 27 minutes

ABBV Jun 2024 160.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
28.940.00 (0.00%)
As of 11:13AM EDT. Market open.
Full screen
Previous close28.94
Open28.94
Bid27.40
Ask30.20
Strike160.00
Expiry date2024-06-21
Day's range26.45 - 28.94
Contract rangeN/A
Volume1
Open interest3
  • Motley Fool

    3 Dividend Aristocrats In Warren Buffett's Secret Portfolio You Can Buy Right Now

    A little-known group of Buffett stocks includes three members of dividend royalty with solid growth prospects.

  • Motley Fool

    Is AbbVie a Buy?

    Drugmaker AbbVie (NYSE: ABBV) is one of the largest healthcare stocks in the world, with a market cap of over $250 billion. AbbVie last reported its earnings in July. Humira remains key to AbbVie's business for now, generating $5.4 billion this past quarter, nearly three times the $1.8 billion Skyrizi and Rinvoq generated.

  • Motley Fool

    Got $1,000? 2 Stocks That Could Be Bargain Buys For 2022 and Beyond

    Let's look at two biotech stocks that look attractive at current levels: AbbVie (NYSE: ABBV) and Gilead Sciences (NASDAQ: GILD). AbbVie is one of the largest pharmaceutical companies around. Like other drugmakers, AbbVie benefits from the fact that doctors do not stop prescribing lifesaving drugs even during challenging economic times, nor do patients stop taking them.